Federal Contractor Profile
Altasciences Clinical Kansas INC
Federal contracting record: $12M obligated across 11 awards from 1 agencies, FY 2016–2026.
Company Profile
UEI (Unique Entity Identifier)
WZ5RGEMMQ3W9
CAGE Code
6PS73
Parent Organization
Altasciences Clinical Kansas INC
Address
10103 METCALF AVE, OVERLAND PARK, KS, 662121758
First Federal Award
Jan 4, 2016
Most Recent Award
Feb 20, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- $12M
Department of Health and Human Services
100.0% of total obligations
Top NAICS Activity
- $7.3M
541715
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
5 awards
- $4.3M
541712
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
2 awards
- $371K
541690
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
1 awards
- $40K
541990
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
3 awards
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Sep 10, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935 | $287K |
| May 2, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. POP: 5/2/2025 - 11/1/2026. N01DA-23-8935 | $1.3M |
| Sep 12, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | INVESTIGATIONAL AGENT SINGLE ASCENDING DOSE SAFETY, TOLERABILITY, AND PK STUDY. SEPTEMBER 3, 2024 TO MARCH 2, 2026. N01DA-23-8935 | $1.4M |
| Jul 31, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935. | $146K |
| Jun 5, 2024 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541715 | DOSE-FINDING STUDY OF KRATOM ALKALOIDS PILOT | $25K |
| Sep 22, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541715 | PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO MARCH 24, 2025. N01DA-23-893 | $1.8M |
| Sep 30, 2021 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541715 | DOSE-FINDING STUDY OF KRATOM ALKALOIDS PILOT | $2.3M |
| Sep 22, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935. | $1.4M |
| Sep 19, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935. | $1.3M |
| Jan 23, 2018 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541690 | IGF::CL::IGF - PROJECT ON PHARMACOKINETICS STUDY OF OPIOID DRUG PRODUCT FOLLOWING INSUFFLATION OF MILLED DRUG PRODUCTS | $67K |
| Sep 20, 2017 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | IGF::OT::IGF: PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935. | $724K |
| Jun 29, 2017 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 541690 | IGF::CL::IGF - PROJECT ON PHARMACOKINETICS STUDY OF OPIOID DRUG PRODUCT FOLLOWING INSUFFLATION OF MILLED DRUG PRODUCTS | $304K |
| Jan 31, 2017 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | IGF::OT::IGF -- OTHER FUNCTION; N01DA-12-8905; PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT | $413K |
| Apr 8, 2016 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 541712 | IGF::OT::IGF -- OTHER FUNCTION; N01DA-12-8905; PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT | $324K |
| Jan 11, 2016 | Department of Health and Human ServicesDEPT OF HHS/FOOD AND DRUG ADMINISTRATION | 541990 | IGF::CL::IGF - PROJECT ON BIOEQUIVALENCE STUDY OF LAMOTRIGINE EXTENDED RELEASE TABLETS. | $40K |
Subawards Received
Altasciences Clinical Kansas INC also receives subaward dollars from other prime contractors. Aggregated from USAspending sub-award reporting (FY2016-FY2026).
Top 1 Primes Paying Altasciences Clinical Kansas INC
- Dynport Vaccine Company LLC$488K
3 subawards
Related Contractors
Other companies active in NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY).
Track Altasciences Clinical Kansas INC Recompetes Before They Post
Mindy monitors Altasciences Clinical Kansas INC's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.
Get Free Recompete Alerts